• Home
  • Pembrolizumab-associated chronic rhinosinusitis: A new endotype and management considerations.

Pembrolizumab-associated chronic rhinosinusitis: A new endotype and management considerations.

Author List
Standiford TC, Patel NN, Singh A, Gochman G, Jamie Wu T, Daud AI, Goldberg AN
Publication
International forum of allergy & rhinology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/410619167
Publication Year
2023
PubMed ID
37317899
Publication Title
Standiford TC, Patel NN, Singh A, Gochman G, Jamie Wu T, Daud AI, Goldberg AN. Pembrolizumab-associated chronic rhinosinusitis: A new endotype and management considerations. Int Forum Allergy Rhinol. 2023 Dec; 13(12):2248-2251.